Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 14-Nov-24 5:00 PM View:  | Maynard Ryan D Director | Iovance Biotherapeutics, Inc. (IOVA) | 12-Nov-24 | Option Sale | 50,000 | $10.06 | $503,000.00 | (87%) 57.5K to 7.5K | |
| 14-Nov-24 5:00 PM View: | Maynard Ryan D Director | Iovance Biotherapeutics, Inc. (IOVA) | 12-Nov-24 | Option Exercise | 50,000 | $7.45 | $372,500.00 | 667% 7.5K to 57.5K | |
| 16-Oct-24 6:33 PM View: | Vogt Frederick G Interim CEO & General Counsel Director | Iovance Biotherapeutics, Inc. (IOVA) | 14-Oct-24 | Payment of Exercise | 8,851 | $9.77 | $86,474.30 | (4%) 213.1K to 204.25K | |
| 16-Oct-24 6:32 PM View: | Graf Finckenstein Friedrich Chief Medical Officer | Iovance Biotherapeutics, Inc. (IOVA) | 14-Oct-24 | Option Exercise | 2,813 | -- | -- | 5% 59.34K to 62.16K | |
| 16-Oct-24 6:30 PM View: | Bilinsky Igor Chief Operating Officer | Iovance Biotherapeutics, Inc. (IOVA) | 14-Oct-24 | Option Exercise | 2,813 | -- | -- | 5% 54.42K to 57.23K | |
| 16-Oct-24 6:33 PM View: | Vogt Frederick G Interim CEO & General Counsel Director | Iovance Biotherapeutics, Inc. (IOVA) | 14-Oct-24 | Option Exercise | 20,834 | -- | -- | 11% 192.26K to 213.1K | |
| 16-Oct-24 6:32 PM View: | Graf Finckenstein Friedrich Chief Medical Officer | Iovance Biotherapeutics, Inc. (IOVA) | 14-Oct-24 | Payment of Exercise | 1,428 | $9.77 | $13,951.60 | (2%) 62.16K to 60.73K | |
| 16-Oct-24 6:30 PM View: | Bilinsky Igor Chief Operating Officer | Iovance Biotherapeutics, Inc. (IOVA) | 14-Oct-24 | Payment of Exercise | 1,428 | $9.77 | $13,951.60 | (2%) 57.23K to 55.81K | |
| 05-Sep-24 7:54 PM View: | Graf Finckenstein Friedrich Chief Medical Officer | Iovance Biotherapeutics, Inc. (IOVA) | 03-Sep-24 | Payment of Exercise | 13,874 | $10.85 | $150,533.00 | (19%) 73.22K to 59.34K | |
| 05-Sep-24 7:53 PM View: | Bilinsky Igor Chief Operating Officer | Iovance Biotherapeutics, Inc. (IOVA) | 03-Sep-24 | Payment of Exercise | 13,675 | $10.85 | $148,374.00 | (20%) 68.1K to 54.42K | |
| 05-Sep-24 7:52 PM View: | Bellemin Jean-Marc Chief Financial Officer | Iovance Biotherapeutics, Inc. (IOVA) | 03-Sep-24 | Option Exercise | 23,438 | -- | -- | 132% 17.8K to 41.24K | |
| 05-Sep-24 7:56 PM View: | Vogt Frederick G Interim CEO & General Counsel Director | Iovance Biotherapeutics, Inc. (IOVA) | 03-Sep-24 | Payment of Exercise | 24,339 | $10.85 | $264,078.00 | (11%) 216.6K to 192.26K | |
| 05-Sep-24 7:54 PM View: | Graf Finckenstein Friedrich Chief Medical Officer | Iovance Biotherapeutics, Inc. (IOVA) | 03-Sep-24 | Option Exercise | 27,345 | -- | -- | 60% 45.87K to 73.22K | |
| 05-Sep-24 7:53 PM View: | Bilinsky Igor Chief Operating Officer | Iovance Biotherapeutics, Inc. (IOVA) | 03-Sep-24 | Option Exercise | 26,954 | -- | -- | 66% 41.14K to 68.1K | |
| 05-Sep-24 7:56 PM View: | Vogt Frederick G Interim CEO & General Counsel Director | Iovance Biotherapeutics, Inc. (IOVA) | 03-Sep-24 | Option Exercise | 57,292 | -- | -- | 36% 159.31K to 216.6K | |
| 05-Sep-24 7:52 PM View: | Bellemin Jean-Marc Chief Financial Officer | Iovance Biotherapeutics, Inc. (IOVA) | 03-Sep-24 | Payment of Exercise | 11,891 | $10.85 | $129,017.00 | (29%) 41.24K to 29.35K | |
| 17-Jul-24 8:01 PM View: | Vogt Frederick G Interim CEO & General Counsel | Iovance Biotherapeutics, Inc. (IOVA) | 15-Jul-24 | Option Exercise | 20,835 | -- | -- | 14% 147.32K to 168.16K | |
| 17-Jul-24 8:01 PM View: | Graf Finckenstein Friedrich Chief Medical Officer | Iovance Biotherapeutics, Inc. (IOVA) | 15-Jul-24 | Payment of Exercise | 1,428 | $8.68 | $12,395.00 | (3%) 47.3K to 45.87K | |
| 17-Jul-24 8:00 PM View: | Bilinsky Igor Chief Operating Officer | Iovance Biotherapeutics, Inc. (IOVA) | 15-Jul-24 | Payment of Exercise | 1,428 | $8.68 | $12,395.00 | (3%) 42.57K to 41.14K | |
| 17-Jul-24 8:01 PM View: | Vogt Frederick G Interim CEO & General Counsel | Iovance Biotherapeutics, Inc. (IOVA) | 15-Jul-24 | Payment of Exercise | 8,851 | $8.68 | $76,826.70 | (5%) 168.16K to 159.31K | |
| 17-Jul-24 8:01 PM View: | Graf Finckenstein Friedrich Chief Medical Officer | Iovance Biotherapeutics, Inc. (IOVA) | 15-Jul-24 | Option Exercise | 2,813 | -- | -- | 6% 44.49K to 47.3K | |
| 17-Jul-24 8:00 PM View: | Bilinsky Igor Chief Operating Officer | Iovance Biotherapeutics, Inc. (IOVA) | 15-Jul-24 | Option Exercise | 2,813 | -- | -- | 7% 39.76K to 42.57K | |
| 05-Jun-24 8:04 PM View: | Vogt Frederick G Interim CEO & General Counsel | Iovance Biotherapeutics, Inc. (IOVA) | 03-Jun-24 | Payment of Exercise | 4,426 | $8.37 | $37,045.60 | (3%) 151.75K to 147.32K | |
| 05-Jun-24 8:07 PM View: | Graf Finckenstein Friedrich Chief Medical Officer | Iovance Biotherapeutics, Inc. (IOVA) | 03-Jun-24 | Option Exercise | 3,906 | -- | -- | 9% 42.56K to 46.47K | |
| 05-Jun-24 8:05 PM View: | Bilinsky Igor Chief Operating Officer | Iovance Biotherapeutics, Inc. (IOVA) | 03-Jun-24 | Option Exercise | 3,516 | -- | -- | 9% 38.03K to 41.54K | |
| 05-Jun-24 8:04 PM View: | Vogt Frederick G Interim CEO & General Counsel | Iovance Biotherapeutics, Inc. (IOVA) | 03-Jun-24 | Option Exercise | 10,417 | -- | -- | 7% 141.33K to 151.75K | |
| 05-Jun-24 8:07 PM View: | Graf Finckenstein Friedrich Chief Medical Officer | Iovance Biotherapeutics, Inc. (IOVA) | 03-Jun-24 | Payment of Exercise | 1,982 | $8.37 | $16,589.30 | (4%) 46.47K to 44.49K | |
| 05-Jun-24 8:05 PM View: | Bilinsky Igor Chief Operating Officer | Iovance Biotherapeutics, Inc. (IOVA) | 03-Jun-24 | Payment of Exercise | 1,784 | $8.37 | $14,932.10 | (4%) 41.54K to 39.76K | |
| 17-Apr-24 7:07 PM View: | Graf Finckenstein Friedrich Chief Medical Officer | Iovance Biotherapeutics, Inc. (IOVA) | 15-Apr-24 | Payment of Exercise | 1,427 | $11.89 | $16,967.00 | (3%) 43.99K to 42.56K | |
| 17-Apr-24 7:07 PM View: | Bilinsky Igor Chief Operating Officer | Iovance Biotherapeutics, Inc. (IOVA) | 15-Apr-24 | Payment of Exercise | 1,427 | $11.89 | $16,967.00 | (4%) 39.45K to 38.03K | |
| 17-Apr-24 7:07 PM View: | Graf Finckenstein Friedrich Chief Medical Officer | Iovance Biotherapeutics, Inc. (IOVA) | 15-Apr-24 | Option Exercise | 2,812 | -- | -- | 7% 41.18K to 43.99K | |
| 17-Apr-24 7:07 PM View: | Bilinsky Igor Chief Operating Officer | Iovance Biotherapeutics, Inc. (IOVA) | 15-Apr-24 | Option Exercise | 2,812 | -- | -- | 8% 36.64K to 39.45K | |
| 17-Apr-24 7:08 PM View: | Vogt Frederick G Interim CEO & General Counsel | Iovance Biotherapeutics, Inc. (IOVA) | 15-Apr-24 | Payment of Exercise | 8,851 | $11.89 | $105,238.00 | (6%) 150.19K to 141.33K | |
| 17-Apr-24 7:08 PM View: | Vogt Frederick G Interim CEO & General Counsel | Iovance Biotherapeutics, Inc. (IOVA) | 15-Apr-24 | Option Exercise | 20,834 | -- | -- | 16% 129.35K to 150.19K | |
| 06-Mar-24 10:00 PM View: | Graf Finckenstein Friedrich Chief Medical Officer | Iovance Biotherapeutics, Inc. (IOVA) | 04-Mar-24 | Payment of Exercise | 8,053 | $16.96 | $136,579.00 | (16%) 49.23K to 41.18K | |
| 06-Mar-24 10:00 PM View: | Bilinsky Igor Chief Operating Officer | Iovance Biotherapeutics, Inc. (IOVA) | 04-Mar-24 | Payment of Exercise | 7,287 | $16.96 | $123,588.00 | (17%) 43.93K to 36.64K | |
| 06-Mar-24 10:00 PM View: | Graf Finckenstein Friedrich Chief Medical Officer | Iovance Biotherapeutics, Inc. (IOVA) | 04-Mar-24 | Option Exercise | 15,623 | -- | -- | 46% 33.61K to 49.23K | |
| 06-Mar-24 10:00 PM View: | Bilinsky Igor Chief Operating Officer | Iovance Biotherapeutics, Inc. (IOVA) | 04-Mar-24 | Option Exercise | 14,061 | -- | -- | 47% 29.87K to 43.93K | |
| 06-Mar-24 10:00 PM View: | Vogt Frederick G Interim CEO & General Counsel | Iovance Biotherapeutics, Inc. (IOVA) | 04-Mar-24 | Payment of Exercise | 11,449 | $16.96 | $194,175.00 | (8%) 140.8K to 129.35K | |
| 06-Mar-24 10:00 PM View: | Vogt Frederick G Interim CEO & General Counsel | Iovance Biotherapeutics, Inc. (IOVA) | 04-Mar-24 | Option Exercise | 41,662 | -- | -- | 42% 99.14K to 140.8K | |
| 20-Feb-24 4:11 PM View: | Rothbaum Wayne P. Director | Iovance Biotherapeutics, Inc. (IOVA) | 20-Feb-24 | Private Purchase | 5,000,000 | $9.15 | $45,750,000.00 | 22% 23.07M to 28.07M | |
| 20-Feb-24 4:21 PM View: | Dukes Iain D. Director | Iovance Biotherapeutics, Inc. (IOVA) | 20-Feb-24 | Private Purchase | 32,000 | $9.15 | $292,800.00 | 145% 22.0K to 54.0K | |
| 20-Feb-24 7:52 PM View: | McPeak Merrill A/ Director | Iovance Biotherapeutics, Inc. (IOVA) | 20-Feb-24 | Private Purchase | 250,000 | $9.15 | $2,287,500.00 | 78% 318.78K to 568.78K | |
| 18-Jan-24 6:09 PM View: | Vogt Frederick G Interim CEO & General Counsel | Iovance Biotherapeutics, Inc. (IOVA) | 16-Jan-24 | Payment of Exercise | 6,530 | $8.37 | $54,656.10 | (6%) 105.67K to 99.14K | |
| 18-Jan-24 6:09 PM View: | Vogt Frederick G Interim CEO & General Counsel | Iovance Biotherapeutics, Inc. (IOVA) | 16-Jan-24 | Option Exercise | 20,834 | -- | -- | 25% 84.83K to 105.67K | |
| 18-Jan-24 6:09 PM View: | Graf Finckenstein Friedrich Chief Medical Officer | Iovance Biotherapeutics, Inc. (IOVA) | 16-Jan-24 | Payment of Exercise | 1,577 | $8.37 | $13,199.50 | (4%) 35.18K to 33.61K | |
| 18-Jan-24 6:07 PM View: | Bilinsky Igor Chief Operating Officer | Iovance Biotherapeutics, Inc. (IOVA) | 16-Jan-24 | Payment of Exercise | 1,577 | $8.37 | $13,199.50 | (5%) 31.44K to 29.87K | |
| 18-Jan-24 6:09 PM View: | Graf Finckenstein Friedrich Chief Medical Officer | Iovance Biotherapeutics, Inc. (IOVA) | 16-Jan-24 | Option Exercise | 2,813 | -- | -- | 9% 32.37K to 35.18K | |
| 18-Jan-24 6:07 PM View: | Bilinsky Igor Chief Operating Officer | Iovance Biotherapeutics, Inc. (IOVA) | 16-Jan-24 | Option Exercise | 2,813 | -- | -- | 10% 28.63K to 31.44K | |
| 18-Oct-23 8:04 PM View: | Bilinsky Igor Chief Operating Officer | Iovance Biotherapeutics, Inc. (IOVA) | 16-Oct-23 | Option Exercise | 2,813 | -- | -- | 10% 27.21K to 30.03K |
